submitted its Q3FY26 monitoring agency report confirming no deviation in the utilization of its ₹3,999.80 crore rights issue proceeds. The company utilized ₹0.65 crore during the quarter for general corporate purposes, maintaining ₹0.21 crore in unutilized funds. CARE Ratings Limited certified full regulatory compliance with SEBI requirements. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.